MedTrace Logo

Corticosteroids in the Treatment of Tuberculous Pleurisy

NCT00338793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2008-08-26

No results posted yet for this study

Summary

Tuberculous pleurisy is associated with inflammation and fibrosis. Adjunctive corticosteroids are used for tuberculous pleurisy because their anti-inflammatory effect is thought to minimise pleural reactivity and thereby reduce residual pleural thickening. The purpose is to evaluate the efficacy and safety of oral prednisolone for treatment of adult patients with tuberculous pleurisy.

Conditions

  • Tuberculous Pleurisy

Interventions

DRUG

prednisolone

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Ministry of Education, China

    collaborator OTHER_GOV

  • Bureau of Science and Technology of Guangxi Province, China

    collaborator UNKNOWN

  • Guangxi Medical University

    lead OTHER

Principal Investigators

  • Huan-Zhong Shi, MD, PhD · Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, China

  • Zhan-Cheng Gao, MD, PhD · Department of Respiratory Diseases, People's Hospital, Peking University, Beijing, China

  • Xin Zhou, MD · Department of Respiratory Diseases, First Affiliated Hospital, Shanghai Jiaotong University, Shanghai, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2008-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00338793 on ClinicalTrials.gov